UDB: You innovation and development partner For over 30 years, UDB (Unither Développement Bordeaux) has developed pharmaceutical formulations to support customers’ development and life cycle objectives. Unither Développement Bordeaux is a GMP-compliant, state-of-the-art facility that features our R&D platforms, an analytical lab and four suites dedicated to manufacturing clinical and commercial batches. Highly trained formulation, analytical and regulatory staff, combined with project management and state-of-the-art equipment, enable Unither to provide both à la carte and comprehensive pharmaceutical development services in a timely manner. Comprehensive services begin with raw material including API*, sourcing, characterization of the API, and go right through industrial transfer. Unither can also provide standalone pharmaceutical development services such as analytical development methods, ICH stability studies and storage, discriminating dissolution development, mineral impurities (in partnership) clinical batch manufacture, and clinical primary packaging. Developpment and manufacturing of Orphan drugs is also part of the center’s capabilities. Formulation development, from lab scale to industrial transfer Formulation Solids (tablets, granules, powder, capsules), liquids (solutions, suspensions, syrups), and semi-solids (creams, ointments, gels, suppositories, vaginal pessaries) Galenical forms Nasal sprays, shampoo, eyewash, multi-unit particle systems, orally disintegrating tablets/granules, liquid-filled hard capsules, bi-layer tablets, and preservative-free liquid formulations Profile Immediate release – modified release (sustained and delayed release) Process management Scale-up validation process and support for technical transfer Lab-scale and industrial troubleshooting Combined with its expertise in managing various stages of development, UDB stands out as a complete partner for its partners. Click here to discover UDB’s new dedicated landing page.
